{"data":{"id":"us/21-cfr-524.1484f","jurisdiction":"us","citation":"21 CFR 524.1484f","heading":"f Neomycin, prednisolone, and tetracaine otic suspension.","body":"(a) Specifications. The product contains 5 milligrams of neomycin sulfate equivalent to 3.5 milligrams of neomycin base, 2.5 milligrams of prednisolone acetate, and 5 milligrams of tetracaine hydrochloride in each milliliter of sterile suspension.\n(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.\n(c) Conditions of use in dogs and cats—(1) Amount. Instill 2 to 6 drops in the external ear canal 2 or 3 times daily.\n(2) Indications for use. For the treatment of acute otitis externa and, to a lesser degree, chronic otitis externa; as treatment or adjunctive therapy of certain ear conditions caused by or associated with neomycin-susceptible organisms and/or allergy.\n(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"4e0f598bfdaa304154b4885a4fe8ecc9c523e676772577cc5758e4e74c8e420d","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-524.1484e","next":"us/21-cfr-524.1484g"},"notice":"GroundRules: Original legal text. Not legal advice."}